Review article: The management of long-term parenteral nutrition

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 6, 2013, Pages 587-603

  Dibb, M ^a   Teubner, A ^a   Theis, V ^a   Shaffer, J ^a   Lal, S ^a  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CHOLINE; GATTEX; GLUCAGON LIKE PEPTIDE 2; GROWTH HORMONE; METHIONINE; PLACEBO; TAUROLIDINE; TEDUGLUTIDE; UNCLASSIFIED DRUG; UROKINASE;

ABSENCE OF SIDE EFFECTS; ARTHRALGIA; AUTOLOGOUS GASTROINTESTINAL RECONSTRUCTION; CARPAL TUNNEL SYNDROME; CATHETER CARE; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER THROMBOSIS; CHOLESTASIS; CHRONIC INTESTINAL FAILURE; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; FATTY LIVER; FEEDING APPARATUS; FOOD STORAGE; GASTROINTESTINAL SURGERY; HEPATOBILIARY DISEASE; HUMAN; INTESTINAL FAILURE; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; INTESTINE FUNCTION; INTESTINE TRANSPLANTATION; INTRAVENOUS FEEDING; KIDNEY DISEASE; LIVER DISEASE; LONG TERM CARE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; METABOLIC BONE DISEASE; MORTALITY; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL PARAMETERS; NUTRITIONAL REQUIREMENT; PARENTERAL FORMULATION STABILITY; PARENTERAL NUTRITION; PARENTERAL NUTRITION INFUSION FREQUENCY; PARENTERAL NUTRITION INFUSION TIMING; PARENTERAL NUTRITION WEANING; PERIPHERAL EDEMA; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; PRODUCT PARAMETERS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT BOWEL SYNDROME; SYSTEMATIC REVIEW; TOXICITY; TREATMENT INDICATION; VASCULAR ACCESS;

CATHETER-RELATED INFECTIONS; CATHETERS; HUMANS; LIVER DISEASES; PARENTERAL NUTRITION, HOME; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84874105758     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12209     Document Type: Review

References (173)

1. Riegel C, Kopp CE,. An evaluation of mixtures of ossein gelatin, hydrolyzed protein, a and glucose in the parenteral nutrition of postoperative patients. Surgery 1949; 25: 672-5.
2. Mann GV, Geyer RP,. Parenteral nutrition; fat emulsions for intravenous nutrition in man. J Lab Clin Med 1949; 34: 699-712.
3. Studley HO,. Percentage of weight loss: a basic indicator of surgical risk in patients with chronic peptic ulcer. 1936. JAMA 1936; 106: 458-60.
4. Jeejeebhoy KN, Zohrab WJ, Langer B, Phillips MJ, Kuksis A, Anderson GH,. Total parenteral nutrition at home for 23 months, without complication, and with good rehabilitation. A study of technical and metabolic features. Gastroenterology 1973; 65: 811-20.
5. Fleming CR,. Intestinal failure. In:, Hill GL, eds. Nutrition and the Surgical Patient. Edinburgh: Churchill Livingstone, 1981; 219-35.
6. Lal S, Teubner A, Shaffer JL,. Review article: intestinal failure. Aliment Pharmacol Ther. 2006; 24: 19-31.
7. Stewart JA, Mason DG, Smith N, Protopapa K, Mason M,. Parenteral Nutrition: A mixed bag. National Confidential Enquiry into Perioperative Deaths; 2010. Available at: http://www.ncepod.org.uk/2010pn.htm. Accessed January 7, 2013.
8. Smith T, Hirst A, Jones B, Baxter J,. Annual BANS Report 2011. British Association of Parenteral and Enteral Nutrition; 2011. Available at: http://www.bapen.org.uk/pdfs/bans-reports/bans-report-11.pdf. Accessed January 7, 2013.
9. Smith T, Hirst A, Jones B, Baxter J,. Annual BANS Report. British association of parenteral and enteral nutrition; 2009. Available at: http://www.bapen.org.uk/pdfs/bans-reports/bans-report-10.pdf. Accessed January 7, 2013.
10. Pironi L, Hebuterne X, Van Gossum A, et al,. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 101: 1633-43.
11. Fernandes G, Kaila B, Jeejeebhoy KN, Gramlich L, Armstrong D, Allard JP,. Canadian Home Parenteral Nutrition (HPN) Registry validation and patient outcomes. J Parenter Enteral Nutr 2012; 36: 407-14.
12. Mullady DK, O'Keefe SJ,. Treatment of intestinal failure: home parenteral nutrition. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 492-504.
13. Takagi Y, Okada A, Sato T, et al,. Report on the first annual survey of home parenteral nutrition in Japan. Surg Today 1995; 25: 193-201.
14. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D,. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? Cancer 2005; 103: 863-8.
15. Brown R, Quercia RA, Sigman R,. Total nutrient admixture: a review. J Parenter Enteral Nutr 1986; 10: 650-8.
16. Staun M, Pironi L, Bozzetti F, et al,. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009; 28: 467-79.
17. Cavicchi M, Beau P, Crenn P, Degott C, Messing B,. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132: 525-32.
18. Wanten GJA, Calder PC,. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007; 85: 1171-84.
19. Mertes N, Grimm H, Fürst P, Stehle P,. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006; 50: 253-9.
20. Silvers KM, Darlow BA, Winterbourn CC,. Pharmacologic levels of heparin do not destabilize neonatal parenteral nutrition. J Parenter Enteral Nutr 1998; 22: 311-4.
21. Mirtallo J, Canada T, Johnson D, et al,. Safe practices for parenteral nutrition. J Parenter Enteral Nutr 2004; 28: S39-70.
22. Lee MD, Yoon J-E, Kim S-I, Kim I-C,. Stability of total nutrient admixtures in reference to ambient temperatures. Nutrition 2003; 19: 886-90.
23. Driscoll DF,. Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards. Curr Opin Clin Nutr Metab Care 2005; 8: 297-303.
24. Allwood MC, Martin HJ,. The photodegradation of vitamins A and E in parenteral nutrition mixtures during infusion. Clin Nutr 2000; 19: 339-42.
25. Balet A, Cardona D, Jane S, et al,. Effects of multilayered bags vs ethylvinyl-acetate bags on oxidation of parenteral nutrition. J Parenter Enteral Nutr 2004; 28: 85-91.
26. Kuwahara T, Asanami S, Kubo S,. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition 1998; 14: 496-501.
27. Randolph AG, Cook DJ, Gonzales CA, Pribble CG,. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 1996; 24: 2053-8.
28. Hind D, Calvert N, McWilliams R, et al,. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327: 361.
29. Keenan SP,. Use of ultrasound to place central lines. J Crit Care 2002; 17: 126-37.
30. NICE. TA49 Central venous catheters-ultrasound locating devices: guidance. 2002. Available at: http://guidance.nice.org.uk/TA49/Guidance/pdf/ English. Accessed January 7, 2013.
31. Maki DG, Alvarado CJ, Ringer M,. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43.
32. Zürcher M, Tramèr MR, Walder B,. Colonization and bloodstream infection with single- versus multi-lumen central venous catheters: a quantitative systematic review. Anesth Analg 2004; 99: 177-82.
33. Cadman A, Lawrance JAL, Fitzsimmons L, Spencer-Shaw A, Swindell R,. To clot or not to clot? That is the question in central venous catheters. Clin Radiol 2004; 59: 349-55.
34. Duerksen DR, Papineau N, Siemens J, Yaffe C,. Peripherally inserted central catheters for parenteral nutrition: a comparison with centrally inserted catheters. J Parenter Enteral Nutr 1999; 23: 85-9.
35. Moureau N, Poole S, Murdock MA, Gray SM, Semba CP,. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 2002; 13: 1009-16.
36. Versleijen MWJ, Huisman-de Waal GJ, Kock MC, et al. Arteriovenous fistulae as an alternative to central venous catheters for delivery of long-term home parenteral nutrition. Gastroenterology 2009; 136: 1577-84.
37. McKinley S, Mackenzie A, Finfer S, Ward R, Penfold J,. Incidence and predictors of central venous catheter related infection in intensive care patients. Anaesth Intensive Care 1999; 27: 164-9.
38. Azizkhan RG, Taylor LA, Jaques PF, Mauro MA, Lacey SR,. Percutaneous translumbar and transhepatic inferior vena caval catheters for prolonged vascular access in children. J Pediatr Surg 1992; 27: 165-9.
39. Denny DF, Dorfman GS, Greenwood LH, Horowitz NR, Morse SS,. Translumbar inferior vena cava Hickman catheter placement for total parenteral nutrition. Am J Roentgenol 1987; 148: 621-2.
40. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M,. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009; 28: 365-77.
41. Saqui O, Chang A, McGonigle S, et al. Telehealth videoconferencing: improving home parenteral nutrition patient care to rural areas of Ontario, Canada. J Parenter Enter Nutr 2007; 31: 234-9.
42. Chambers A, Hennessy E, Powell-Tuck J,. Longitudinal trends in quality of life after starting home parenteral nutrition: A randomised controlled study of telemedicine. Clin Nutr 2006; 25: 505-14.
43. Nehme AE,. Nutritional support of the hospitalized patient: the team concept. JAMA 1980; 243: 1906-8.
44. Goldstein M, Braitman LE, Levine GM,. The medical and financial costs associated with termination of a nutrition support nurse. J Parenter Enteral Nutr 2000; 24: 323-7.
45. Sutton CD, Garcea G, Pollard C, Berry DP, Dennison AR,. The introduction of a nutrition clinical nurse specialist results in a reduction in the rate of catheter sepsis. Clin Nutr 2005; 24: 220-3.
46. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C,. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999; 117: 1043-50.
47. Dibb M, Carlson G, Abraham A, Shaffer J, Teubner A, Lal S,. OC-034 Salvage of central venous catheters in HPN catheter-related blood stream infections is safe and effective: 18 years experience from a national centre. Gut 2012; 61: A14-5.
48. Lloyd DAJ, Vega R, Bassett P, Forbes A, Gabe SM,. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment Pharmacol Ther 2006; 24: 1231-40.
49. Vantini I, Benini L, Bonfante F, et al. Survival rate and prognostic factors in patients with intestinal failure. Digest Liver Dis 2004; 36: 46-55.
50. Crispin A, Thul P, Arnold D, Schild S, Weimann A,. Central venous catheter complications during home parenteral nutrition: a prospective pilot study of 481 patients with more than 30,000 catheter days. Onkologie 2008; 31: 605-9.
51. Marra AR, Opilla M, Edmond MB, Kirby DF,. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 2007; 41: 19-28.
52. Gales BJ, Gales MJ,. Nutritional support teams: a review of comparative trials. Ann Pharmacother 1994; 28: 227-35.
53. Oakes L, Anseline M, Carlton J,. Reduction of complications associated with total parenteral nutrition by introduction of a clinical monitoring team. The Total Parenteral Nutrition Committee. Aust Clin Rev 1991; 11: 138-42.
54. Faubion WC, Wesley JR, Khalidi N, Silva J,. Total parenteral nutrition catheter sepsis: impact of the team approach. J Parenter Enteral Nutr 1986; 10: 642-5.
55. Bozzetti F, Mariani L, Bertinet DB, et al. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100.000 catheter days. Clin Nutr 2002; 21: 475-85.
56. Richards DM, Scott NA, Shaffer JL, Irving M,. Opiate and sedative dependence predicts a poor outcome for patients receiving home parenteral nutrition. J Parenter Enteral Nutr 1997; 21: 336-8.
57. Jurewitsch B, Jeejeebhoy KN,. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr 2005; 24: 462-5.
58. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ,. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr 1988; 12: 185-9.
59. Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ,. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 2010; 29: 464-8.
60. Clare A, Teubner A, Shaffer JL,. What information should lead to a suspicion of catheter sepsis in HPN? Clin Nutr 2008; 27: 552-6.
61. Santarpia L, Alfonsi L, Tiseo D, et al. Central venous catheter infections and antibiotic therapy during long-term home parenteral nutrition an 11-year follow-up study. J Parenter Enteral Nutr 2010; 34: 254-62.
62. Messing B, Man F, Colimon R, Thuillier F, Beliah M,. Antibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin Nutr 1990; 9: 220-5.
63. Richards DM, Deeks JJ, Sheldon TA, Shaffer JL,. Home parenteral nutrition: a systematic review. Health Technol Assess 1997; 1: i-iii.
64. McMahon M, Teubner A, Shaffer JL, Lal S,. Endoluminal brushing of occluded long term parenteral nutrition catheters is associated with a reduced need for catheter replacement. Gastroenterology 2011; 140: S171.
65. Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER,. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12: 951-5.
66. Glynn MF, Langer B, Jeejeebhoy KN,. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. J Parenter Enteral Nutr 1980; 4: 387-90.
67. Jacobs BR, Haygood M, Hingl J,. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001; 139: 593-6.
68. Werlin SL, Lausten T, Jessen S, et al. Treatment of central venous catheter occlusions with ethanol and hydrochloric acid. J Parenter Enteral Nutr 1995; 19: 416-8.
69. Duerksen DR, Ahmad A, Doweiko J, Bistrian BR, Mascioli EA,. Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition. J Parenter Enteral Nutr 1996; 20: 302-5.
70. Cotogni P, Pittiruti M, Barbero C, Monge T, Palmo A, Bertinet DB,. Catheter-related complications in cancer patients on home parenteral nutrition a prospective study of over 51,000 catheter days. J Parenter Enteral Nutr 2012. Available at: http://pen.sagepub.com/content/early/2012/09/18/0148607112460552. Accessed January 7, 2013.
71. Wechsler RJ, Spirn PW, Conant EF, Steiner RM, Needleman L,. Thrombosis and infection caused by thoracic venous catheters: pathogenesis and imaging findings. Am J Roentgenol 1993; 160: 467-71.
72. Klerk CPW, Smorenburg SM, Buller HR,. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med 2003; 163: 1913-21.
73. Veerabagu MP, Tuttle-Newhall J, Maliakkal R, Champagne C, Mascioli EA,. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients. Nutrition 1995; 11: 142-4.
74. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous cathetersL a randomized prospective trial. Ann Intern Med 1990; 112: 423-8.
75. Gould JR, Carloss HW, Skinner WL,. Groshong catheter-associated subclavian venous thrombosis. Am J Med 1993; 95: 419-23.
76. Leinhardt DJ, Carlson GL, Williams N,. Occlusion of silastic broviac catheters as a result of twisting between the catheter and hub assembly. Clin Nutr 1993; 12: 243-5.
77. Beau P, Matrat S,. A comparative study of polyurethane and silicone cuffed-catheters in long-term home total parenteral nutrition patients. Clin Nutr 1999; 18: 175-7.
78. Yeung C-W, Cheung WWW, Leung AYH, Kwong Y-L,. Spontaneous central venous catheter fracture: relevance of the pinch-off sign. J Hosp Med 2010; 5: E33.
79. Reddy A, Stangl A, Radbill B,. Retained catheter fragment from a fractured tunneled catheter-a rare and potentially lethal complication. Semin Dial 2010; 23: 536-9.
80. Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI,. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992; 33: 1493-7.
81. Nightingale JMD,. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 2003; 17: 907-29.
82. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999; 126: 28-34.
83. Pironi L, Paganelli F, Labate AMM, et al. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre. Dig Liver Dis 2003; 35: 314-24.
84. Knafelz D, Gambarara M, Diamanti A, et al. Complications of home parenteral nutrition in a large pediatric series. Transplant Proc 2003; 35: 3050-1.
85. Luman W, Shaffer JL,. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 2002; 21: 337-43.
86. Gabe SM, Culkin A,. Abnormal liver function tests in the parenteral nutrition fed patient. Frontline Gastroenterol 2010; 1: 98-104.
87. Kalaiselvan R, Jhalini J, Lal S, Carlson GL,. Aetiology, management of jaundice in adult patients with acute severe intestinal failure. Gastroenterology 2011; 140: S864.
88. Wolfe BM, Walker BK, Shaul DB, Wong L, Ruebner BH,. Effect of total parenteral nutrition on hepatic histology. Arch Surg 1988; 123: 1084-90.
89. Dray X, Joly F, Reijasse D, et al. Incidence, risk factors, and complications of cholelithiasis in patients with home parenteral nutrition. J Am College Surgeons 2007; 204: 13-21.
90. Kaji T, Takamatsu H, Kajiya H,. Motility of the gastrointestinal tract and gallbladder during long-term total parenteral nutrition in dogs. J Parenter Enteral Nutr 2002; 26: 198-204.
91. Doty JE, Pitt HA, Porter-Fink V, Denbesten L,. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg 1985; 201: 76-80.
92. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC,. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990; 170: 25-31.
93. Nealon WH, Upp JR Jr, Alexander RW, Gomez G, Townsend CM Jr, Thompson JC,. Intravenous amino acids stimulate human gallbladder emptying and hormone release. Am J Physiol 1990; 259: G173-8.
94. Zoli G, Ballinger A, Healy J, O'Donnell LJ, Clark M, Farthing MJ,. Promotion of gallbladder emptying by intravenous aminoacids. Lancet 1993; 341: 1240-1.
95. Wu ZS, Yu L, Lin YJ, et al. Rapid intravenous administration of amino acids prevents biliary sludge induced by total parenteral nutrition in humans. J Hepatobiliary Pancreat Surg 2000; 7: 504-9.
96. Dhiman RK, Reddi R, Sharma A, et al. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones. J Gastroenterol Hepatol 2001; 16: 816-20.
97. Thompson JS,. The role of prophylactic cholecystectomy in the short-bowel syndrome. Arch Surg 1996; 131: 556-9.
98. Allardyce DB,. Cholestasis caused by lipid emulsions. Surg Gynecol Obstet 1982; 154: 641-7.
99. Klein GL, Alfrey AC, Miller NL, et al. Aluminum loading during total parenteral nutrition. Am J Clin Nutr 1982; 35: 1425-9.
100. Lloyd DAJ, Gabe SM,. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007; 66: 530-8.
101. Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J Parenter Enteral Nutr 2001; 25: 260-8.
102. Vinton NE, Laidlaw SA, Ament ME, Kopple JD,. Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition. Am J Clin Nutr 1986; 44: 398-404.
103. National Institute of Clinical Excellence. Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition. 2006. Available at: http://guidance.nice.org.uk/CG32/Guidance/pdf/English. Accessed January 7, 2013.
104. Naini BV, Lassman CR,. Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation. Hum Pathol 2012 Jun; 43: 826-33.
105. Fallon EM, Le HD, Puder M,. Prevention of parenteral nutrition-associated liver disease: role of ω-3 fish oil. Curr Opin Organ Transplant 2010; 15: 334-40.
106. Tomsits E, Pataki M, Tölgyesi A, Fekete G, Rischak K, Szollár L,. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010; 51: 514-21.
107. Hwang TL, Lue MC, Chen LL,. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogastroenterology 2000; 47: 1347-50.
108. Buchman AL, Sohel M, Moukarzel A, et al,. Plasma choline in normal newborns, infants, toddlers, and in very-low-birth-weight neonates requiring total parenteral nutrition. Nutrition 2001 Jan; 17: 18-21.
109. Heird WC, Dell RB, Helms RA, et al,. Amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children requiring parenteral nutrition. Pediatrics 1987; 80: 401-8.
110. De Marco G, Sordino D, Bruzzese E, et al,. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther 2006; 24: 387-94.
111. Spencer AU, Yu S, Tracy TF, et al,. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. J Parenter Enteral Nutr 2005; 29: 337-43.
112. Schneider SM, Joly F, Gehrardt M-F, et al,. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study. Br J Nutr 2006; 96: 365-70.
113. Shike M, Harrison JE, Sturtridge WC, et al,. Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med 1980; 92: 343-50.
114. Ott SM, Maloney NA, Klein GL, et al,. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 1983; 98: 910-4.
115. Raman M, Aghdassi E, Baun M, et al,. Metabolic bone disease in patients receiving home parenteral nutrition: a canadian study and review. J Parenter Enter Nutr 2006; 30: 492-6.
116. Ferrone M, Geraci M,. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Pract 2007; 22: 329-39.
117. Pironi L, Morselli-Labate A, Pertkiewicz M, et al,. Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr 2002; 21: 289-96.
118. Fitzgerald KA, MacKay MW,. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing TrophAmine. Am J Hosp Pharm 1986; 43: 88-93.
119. Haderslev KV, Jeppesen PB, Hartmann B, et al,. Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol 2002; 37: 392-8.
120. Gottschalck IB, Jeppesen PB, Hartmann B, Holst JJ, Henriksen DB,. Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome. Scand J Gastroenterol 2008; 43: 1304-10.
121. Carbonnel F, Cosnes J, Chevret S, et al,. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. J Parenter Enteral Nutr 1996; 20: 275-80.
122. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B,. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119: 1496-505.
123. Picot D, Garin L, Trivin F, Kossovsky MP, Darmaun D, Thibault R,. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure. Clin Nutr 2010; 29: 235-42.
124. Sukhotnik I, Gork AS, Chen M, Drongowski RA, Coran AG, Harmon CM,. Effect of a high fat diet on lipid absorption and fatty acid transport in a rat model of short bowel syndrome. Pediatr Surg Int 2003; 19: 385-90.
125. Keelan M, Cheeseman CI, Clandinin MT, Thomson AB,. Intestinal morphology and transport after ileal resection in rat is modified by dietary fatty acids. Clin Invest Med 1996; 19: 63-70.
126. Diamond JM, Karasov WH, Cary C, Enders D, Yung R,. Effect of dietary carbohydrate on monosaccharide uptake by mouse small intestine in vitro. J Physiol (Lond) 1984; 349: 419-40.
127. Wirén ME, Permert J, Skullman SP, Wang F, Larsson J,. No differences in mucosal adaptive growth one week after intestinal resection in rats given enteral glutamine supplementation or deprived of glutamine. Eur J Surg 1996; 162: 489-98.
128. Dumas F, De Bandt JP, Colomb V, et al,. Enteral ornithine alpha-ketoglutarate enhances intestinal adaptation to massive resection in rats. Metab, Clin Exp 1998; 47: 1366-71.
129. Seguy D, Vahedi K, Kapel N, Souberbielle J-C, Messing B,. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124: 293-302.
130. Byrne TA, Cox S, Kirimbakas M, Veglia LM, Bennett HM, Lautz DB, Robinson MK, Wilmore DW, Veglia LM,. Bowel rehabilitation: an alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome. Tranaplant proc 2002; 34: 887-90.
131. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW,. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222: 243-54.
132. Weiming Z, Ning L, Jieshou L,. Effect of recombinant human growth hormone and enteral nutrition on Sshort bowel syndrome. J Parenter Enteral Nutr 2004; 28: 377-81.
133. Byrne TA, Wilmore DW, Iyer K, Dibaise J, Clancy K, Robinson MK, Chang P, Gertner JM, Lautz D,. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann. Surg 2005; 242: 655-61.
134. Ellegard L, Bosaeus I, Nordgren S, Bengtsson BA,. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann. Surg 1997; 225: 88-96.
135. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG,. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113: 1074-81.
136. Szkudlarek J, Jeppesen PB, Mortensen PB,. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double blind, crossover, placebo controlled study. Gut 2000; 47: 199-205.
137. Sham J, Martin G, Meddings JB, Sigalet DL,. Epidermal growth factor improves nutritional outcome in a rat model of short bowel syndrome. J Pediatr Surg 2002; 37: 765-9.
138. Lemmey AB, Ballard FJ, Martin AA, Tomas FM, Howarth GS, Read LC,. Treatment with IGF-I peptides improves function of the remnant gut following small bowel resection in rats. Growth Factors 1994; 10: 243-52.
139. Gillingham MB, Dahly EM, Carey HV, Clark MD, Kritsch KR, Ney DM,. Differential jejunal and colonic adaptation due to resection and IGF-I in parenterally fed rats. Am J Physiol Gastrointest Liver Physiol 2000; 278: G700-9.
140. Peterson CA, Gillingham MB, Mohapatra NK, et al,. Enterotrophic effect of insulin-like growth factor-I but not growth hormone and localized expression of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and -5 mRNAs in jejunum of parenterally fed rats. J Parenter Enteral Nutr 2000; 24: 288-95.
141. Yang H, Wildhaber BE, Teitelbaum DH,. 2003 Harry M Vars Research Award. Keratinocyte growth factor improves epithelial function after massive small bowel resection. J Parenter Enteral Nutr 2003; 27: 198-206.
142. Pearson PY, O'Connor DM, Schwartz MZ,. Novel effect of leptin on small intestine adaptation. J Surg Res 2001; 97: 192-5.
143. Kunkel D, Basseri B, Low K, et al,. Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterol Motil 2011; 23: 739-e328.
144. Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ,. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011; 60: 902-14.
145. Jeppesen PB, Pertkiewicz M, Messing B, et al,. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012; 143: 1473-81.
146. Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB,. Teduglutide (ALX-0600) a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut; 54: 1224-31.
147. Jeppesen PB, Hartman B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB,. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001; 120: 806-15.
148. Wales PW, Nasr A, De Silva N, Yamada J,. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 1996. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006321.pub2/abstract. Accessed January 7, 2013.
149. Swerdlow A, Higgins C, Adlard P, Preece M,. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002; 360: 273-7.
150. Giovannucci E, Pollak M,. Risk of cancer after growth-hormone treatment. Lancet 2002; 360: 268-9.
151. Baxter JP, Fayers PM, McKinlay AW,. A review of the quality of life of adult patients treated with long-term parenteral nutrition. Clin Nutr 2006; 25: 543-53.
152. Dibb M, Carlson G, Bradley A, et al,. OC-032 Outcome on home parenteral nutrition: 33 years experience from a national centre. Gut 2012; 61: A14.
153. Richards DM, Irving MH,. Cost-utility analysis of home parenteral nutrition. Br J Surg 1996; 83: 1226-9.
154. Pironi L, Paganelli F, Mosconi P, et al,. The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. Transplant Proc 2004; 36: 255-8.
155. Jeppesen PB, Langholz E, Mortensen PB,. Quality of life in patients receiving home parenteral nutrition. Gut 1999; 44: 844-52.
156. Messing B, Lémann M, Landais P, et al,. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995; 108: 1005-10.
157. Scolapio JS, Fleming CR, Kelly DG, Wick DM, Zinsmeister AR,. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 1999; 74: 217-22.
158. Amiot A, Messing B, Corcos O, Panis Y, Joly F,. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Available at: http://dx.doi.org/10.1016/j.clnu.2012.08. 007. Accessed January 7, 2013.
159. Fan B-G,. Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. J Parenter Enteral Nutr 2007; 31: 508-10.
160. Pironi L, Joly F, Forbes A, et al,. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 2011; 60: 17-25.
161. DeLegge M, Alsolaiman MM, Barbour E, Bassas S, Siddiqi MF, Moore NM,. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today? Dig Dis Sci 2007; 52: 876-92.
162. Buchman AL, Scolapio J, Fryer J,. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111-34.
163. Kaufman SS, Atkinson JB, Bianchi A, et al,. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant 2001; 5: 80-7.
164. Abu-Elmagd KM, Mazariegos G,. Intestinal transplantation and the European implication: impact of experience and study design. Gut 2012; 61: 166.
165. Pironi L, Forbes A, Van Gossum A, Home Artificial Nutrition & Chronic Intestinal Failure Working Group of the European Society for Clinical Nutrition and Metabolism (ESPEN). The authors' reply. Gut 2012; 61: 167.
166. Weber TR,. Isoperistaltic bowel lengthening for short bowel syndrome in children. Am J Surg 1999; 178: 600-3.
167. Ching YA, Fitzgibbons S, Valim C, et al,. Long-term nutritional and clinical outcomes after serial transverse enteroplasty at a single institution. J Pediatr Surg 2009; 44: 939-43.
168. Wales PW, De Silva N, Langer JC, Fecteau A,. Intermediate outcomes after serial transverse enteroplasty in children with short bowel syndrome. J Pediatr Surg 2007; 42: 1804-10.
169. Modi BP, Javid PJ, Jaksic T, et al,. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am College Surgeons 2007; 204: 365-71.
170. Sudan D, Thompson J, Botha J, et al,. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007; 246: 593-601.
171. Yannam GR, Sudan DL, Grant W, Botha J, Langnas A, Thompson JS,. Intestinal lengthening in adult patients with short bowel syndrome. J Gastrointest Surg 2010; 14: 1931-6.
172. Bianchi A,. Intestinal loop lengthening-a technique for increasing small intestinal length. J Pediatr Surg 1980; 15: 145-51.
173. Kim HB, Fauza D, Garza J, Oh J-T, Nurko S, Jaksic T,. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003; 38: 425-9.